Literature DB >> 9834264

Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis.

D P Hirsch1, R H Holloway, G N Tytgat, G E Boeckxstaens.   

Abstract

BACKGROUND & AIMS: Nitric oxide (NO) is well accepted as an inhibitory neurotransmitter in the gastrointestinal tract; however, its role in the triggering of transient lower esophageal sphincter relaxations (TLESRs) in humans remains to be determined. Therefore, the effect of NG-monomethyl-L-arginine (L-NMMA), a specific NO synthase blocker, on gastric distention-induced TLESRs was investigated.
METHODS: Esophageal manometry was performed using a perfused sleeve assembly. The effect of L-NMMA was evaluated on water swallow-evoked primary peristalsis (n = 8; single-blind, placebo-controlled) and on the rate of TLESRs during gastric distention (n = 8; double-blind, placebo-controlled).
RESULTS: L-NMMA increased the amplitude of peristaltic pressure waves in the distal esophagus and increased peristaltic velocity in the proximal esophagus. In contrast, L-NMMA had no effect on basal lower esophageal sphincter pressure, nadir pressure, duration, and area under the curve of lower esophageal sphincter relaxation. L-NMMA significantly inhibited the increase in TLESRs during gastric distention. L-NMMA also increased the intraballoon pressure during distention.
CONCLUSIONS: NO is one of the neurotransmitters involved in the reflex arc mediating the triggering of TLESRs. NO is involved in the timing of human esophageal peristalsis and may exert a tonic inhibition on the proximal stomach.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9834264     DOI: 10.1016/s0016-5085(98)70015-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  30 in total

1.  Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer?

Authors:  Shyam Menon; Peter Nightingale; Nigel Trudgill
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

2.  Population based study to assess prevalence and risk factors of gastroesophageal reflux disease in a high altitude area.

Authors:  Sushil Kumar; Saurabh Sharma; Tsering Norboo; Diskit Dolma; Angchuk Norboo; Tsering Stobdan; S Rohatgi; K Munot; Vineet Ahuja; Anoop Saraya
Journal:  Indian J Gastroenterol       Date:  2010-12-23

3.  Do Statins Increase the Risk of Esophageal Conditions? Findings from Four Propensity Score-Matched Analyses.

Authors:  Ioana Smith; Robert Schmidt; Ethan A Halm; Ishak A Mansi
Journal:  Clin Drug Investig       Date:  2018-02       Impact factor: 2.859

4.  Effects of sildenafil on esophageal motility of normal subjects.

Authors:  M Bortolotti; C Mari; M Giovannini; S Pinna; M Miglioli; N Pandolfo
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

5.  Is glutamate involved in transient lower esophageal sphincter relaxations?

Authors:  D P Hirsch; G N J Tytgat; G E E Boeckxstaens
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 6.  Chronic Burping and Belching.

Authors:  M Zad; A J Bredenoord
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-23

Review 7.  Neuro-regulation of lower esophageal sphincter function as treatment for gastroesophageal reflux disease.

Authors:  Anupender Singh Sidhu; George Triadafilopoulos
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

8.  Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins.

Authors:  Helena Nordenstedt; Zongli Zheng; Alan J Cameron; Weimin Ye; Nancy L Pedersen; Jesper Lagergren
Journal:  Gastroenterology       Date:  2008-01-11       Impact factor: 22.682

9.  Myenteric nitrergic neurons along the rat esophagus: evidence for regional and strain differences in age-related changes.

Authors:  Mei Wu; Luc Van Nassauw; Alfons B A Kroese; Dirk Adriaensen; Jean-Pierre Timmermans
Journal:  Histochem Cell Biol       Date:  2003-04-30       Impact factor: 4.304

10.  The effects of nebulized albuterol on esophageal function in asthmatic patients.

Authors:  Brian E Lacy; Carole Mathis; John DesBiens; Mark C Liu
Journal:  Dig Dis Sci       Date:  2008-02-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.